FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1320-1322 April 25, 2002 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Sampson, H. A. PubMed Citation

In this issue of the Journal, Sampson¹ reviews the clinical features of allergy to peanuts. The question is why, in a small but apparently increasing percentage of the population, does the ingestion of a seemingly innocuous and healthful food result in an allergic reaction?

The clinical manifestations of an allergic reaction to foods are the end result of an orchestrated series of events involving the immune system that have their origins in a prior exposure to the offending allergen (Figure 1). During the initial exposure, which may occur in utero, during breast-feeding, or in early childhood, antibodies of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Leung, D. Y.M., Sampson, H. A., Yunginger, J. W., Burks, A. W. Jr., Schneider, L. C., Wortel, C. H., Davis, F. M., Hyun, J. D., Shanahan, W. R. Jr., the TNX-901 Peanut Allergy Study Group, (2003). Effect of Anti-IgE Therapy in Patients with Peanut Allergy. NEJM 348: 986-993 [Abstract] [Full Text]